Encompass Health Corporation
EHC
$122.83
-$0.60-0.49%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 522.70M | 494.70M | 455.70M | 422.40M | 399.50M |
Total Depreciation and Amortization | 315.50M | 308.50M | 299.60M | 291.70M | 280.60M |
Total Amortization of Deferred Charges | 9.70M | 9.70M | 9.70M | 9.50M | 9.50M |
Total Other Non-Cash Items | 233.60M | 223.70M | 215.90M | 190.90M | 187.30M |
Change in Net Operating Assets | 23.90M | 16.00M | 21.90M | 10.50M | -4.50M |
Cash from Operations | 1.11B | 1.05B | 1.00B | 925.00M | 872.40M |
Capital Expenditure | -666.20M | -666.20M | -642.50M | -655.50M | -657.70M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -22.90M | -15.90M | -10.80M | -2.20M | -700.00K |
Cash from Investing | -689.10M | -682.10M | -653.30M | -657.70M | -658.40M |
Total Debt Issued | 105.00M | 105.00M | 95.00M | 65.00M | 50.00M |
Total Debt Repaid | -376.20M | -367.00M | -337.00M | -225.70M | -96.20M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -91.00M | -83.00M | -43.20M | -35.80M | -29.40M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -67.10M | -64.90M | -62.80M | -60.70M | -60.70M |
Other Financing Activities | -31.70M | -10.50M | 17.40M | 47.60M | -49.60M |
Cash from Financing | -461.00M | -420.40M | -330.60M | -209.60M | -185.90M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -44.70M | -49.90M | 18.90M | 57.70M | 28.10M |